Alignment Healthcare (NASDAQ:ALHC – Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued to investors on Saturday.
Several other research firms also recently issued reports on ALHC. UBS Group boosted their price objective on shares of Alignment Healthcare from $17.00 to $18.00 and gave the stock a “neutral” rating in a research note on Friday, October 31st. The Goldman Sachs Group reaffirmed a “buy” rating and set a $22.00 price target on shares of Alignment Healthcare in a research report on Monday, November 3rd. JPMorgan Chase & Co. increased their price target on Alignment Healthcare from $17.00 to $18.00 and gave the company a “neutral” rating in a report on Wednesday, November 5th. KeyCorp raised Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 target price for the company in a research report on Monday, August 25th. Finally, Zacks Research lowered Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 28th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Alignment Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $19.85.
Check Out Our Latest Report on Alignment Healthcare
Alignment Healthcare Stock Performance
Alignment Healthcare (NASDAQ:ALHC – Get Free Report) last issued its earnings results on Thursday, October 30th. The company reported $0.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.03. The business had revenue of $993.70 million during the quarter, compared to analysts’ expectations of $980.90 million. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.The company’s revenue for the quarter was up 43.5% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.14) EPS. Alignment Healthcare has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. As a group, research analysts forecast that Alignment Healthcare will post -0.69 earnings per share for the current year.
Insider Activity at Alignment Healthcare
In related news, Director Atlantic (Aln Hlth) L. General sold 6,246,096 shares of the business’s stock in a transaction dated Wednesday, September 17th. The stock was sold at an average price of $16.01, for a total value of $99,999,996.96. Following the transaction, the director owned 24,596,079 shares in the company, valued at approximately $393,783,224.79. The trade was a 20.25% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Hyong Kim sold 51,379 shares of the stock in a transaction dated Thursday, October 9th. The shares were sold at an average price of $17.57, for a total value of $902,729.03. Following the completion of the transaction, the insider directly owned 362,333 shares of the company’s stock, valued at $6,366,190.81. This represents a 12.42% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 7,409,116 shares of company stock valued at $119,379,625. 6.60% of the stock is currently owned by insiders.
Institutional Trading of Alignment Healthcare
A number of hedge funds have recently made changes to their positions in ALHC. Teacher Retirement System of Texas raised its holdings in shares of Alignment Healthcare by 109.1% during the first quarter. Teacher Retirement System of Texas now owns 47,447 shares of the company’s stock worth $883,000 after purchasing an additional 24,755 shares during the period. New York State Common Retirement Fund boosted its holdings in shares of Alignment Healthcare by 100.9% in the 1st quarter. New York State Common Retirement Fund now owns 165,642 shares of the company’s stock valued at $3,084,000 after buying an additional 83,187 shares during the period. Victory Capital Management Inc. grew its position in shares of Alignment Healthcare by 905.7% during the 1st quarter. Victory Capital Management Inc. now owns 114,397 shares of the company’s stock valued at $2,130,000 after buying an additional 103,022 shares during the last quarter. Raymond James Financial Inc. grew its position in shares of Alignment Healthcare by 31.1% during the 1st quarter. Raymond James Financial Inc. now owns 206,174 shares of the company’s stock valued at $3,839,000 after buying an additional 48,901 shares during the last quarter. Finally, Strs Ohio acquired a new stake in Alignment Healthcare during the first quarter worth about $600,000. Institutional investors and hedge funds own 86.19% of the company’s stock.
Alignment Healthcare Company Profile
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Further Reading
- Five stocks we like better than Alignment Healthcare
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- 3 Big Earnings Misses: Is It Time to Buy the Dip?
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Is Robinhood’s 11% Post-Earnings Fall a Buy-the-Dip Opportunity?
- What Makes a Stock a Good Dividend Stock?
- AI Demand Is Coming—Is Microchip Technology Ready?
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
